ISOGENICA

isogenica-logo

Isogenica Limited, a biotechnology company, develops therapeutic peptides to treat diseases. The company's vitro display technology, CIS display is used to discover biologically active peptides, proteins, and antibodies. Isogenica Limited was founded in 2000 and is based in Cambridge, the United Kingdom.

#SimilarOrganizations #People #Financial #Website #More

ISOGENICA

Social Links:

Industry:
Biopharma Biotechnology Health Care Life Science

Founded:
2000-01-01

Address:
Cambridge, Cambridgeshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.isogenica.com

Total Employee:
11+

Status:
Active

Contact:
+44 1799 533680

Email Addresses:
[email protected]

Total Funding:
9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Current Employees Featured

emma-sceats_image

Emma Sceats
Emma Sceats CEO @ Isogenica
CEO
2018-09-01

anthony-m-nixon_image

Anthony M. Nixon
Anthony M. Nixon General Counsel @ Isogenica
General Counsel

chris-ullman_image

Chris Ullman
Chris Ullman CSO @ Isogenica
CSO

Founder


kevin-fitzgerald_image

Kevin FitzGerald

Acquisitions List

Date Company Article Price
2008-05-06 Karyon-CTT Karyon-CTT acquired by Isogenica N/A

Investors List

innovate-u-k-_image

Innovate UK

Innovate UK investment in Grant - Isogenica

Official Site Inspections

http://www.isogenica.com Semrush global rank: 6.93 M Semrush visits lastest month: 687

  • Host name: grh70.myukcloud.com
  • IP address: 5.134.14.106
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Isogenica"

VHH single-domain antibodies | ISOGENICA

Isogenica announces two Pioneering Collaborations with an Antibody Research and License Agreement, and an Asset Evaluation Deal Isogenica, a leading innovator in VHH antibodies, is โ€ฆSee details»

Isogenica - Crunchbase Company Profile & Funding

Isogenica Limited, a biotechnology company, develops therapeutic peptides to treat diseases. The company's vitro display technology, CIS display is used to discover biologically active โ€ฆSee details»

Isogenica Company Profile | Management and Employees List

Isogenica is a drug discovery platform-licensing company focusing on the design and build of diverse, fully synthetic, antibody libraries for use in biopharmaceutical discovery. Partners can โ€ฆSee details»

Isogenica - LinkedIn

Isogenica is a bespoke biotech CRO specialised in solving antibody discovery and engineering challenges with small-format antibodies, particularly VHH single-domains.See details»

Isogenica Company Profile 2024: Valuation, Funding & Investors

Isogenica was founded in 1998. Where is Isogenica headquartered? Isogenica is headquartered in Essex, United Kingdom. What is the size of Isogenica? Isogenica has 21 total employees. โ€ฆSee details»

Isogenica Overview | SignalHire Company Profile

Isogenica Overview Summary. Isogenica is a bespoke biotech CRO specialised in solving antibody discovery and engineering challenges with small-format antibodies, particularly VHH โ€ฆSee details»

Isogenica turns 25: Our journey

May 2, 2023 Isogenica is a biotechnology company specializing in the discovery and development of small format single chain VHH antibodies. We are leaders in our domain, having developed a fully synthetic, in vitro plug-and-play cassette โ€ฆSee details»

Isogenica - VentureRadar

Isogenica is a biotech CRO specializing in VHH antibody discovery and engineering. Utilizing the largest and most diverse synthetic VHH libraries combined with proprietary CIS display โ€ฆSee details»

Isogenica Limited Information - RocketReach

Isogenica is a bespoke biotech CRO specialised in solving antibody discovery and engineering challenges with small-format antibodies, particularly VHH single-domains. Sometimes known โ€ฆSee details»

Isogenica turns 25: A beautiful journey - BioPartner UK

May 2, 2023 Our journey started in May 1998, when Isogenica was spun out from Swedish biotech company ActiNova. Having been initially named Pharmacophorix, the name was โ€ฆSee details»

Isogenica Company Profile - Office Locations, Competitors ... - Craft

Isogenica is a company that develops LlamdA VHH, versatile small-format antibodies that utilizing to construct biotherapeutics for the treatment of cancer, inflammation, and other serious โ€ฆSee details»

Looking for a partner in antibody discovery? - Isogenica

Partner with us for antibody discovery and experience a tailored and collaborative approach to contract research organization services. About Us. About Us; Our Team; Board of Directors; โ€ฆSee details»

Isogenica - Products, Competitors, Financials, Employees, โ€ฆ

Isogenica Photo credits: Chris Isogenica is an expert in the discovery of small-format antibodies, with a specialist focus on camelid-derived VHHs, which the company says offer exceptional โ€ฆSee details»

Isogenica | Scientist.com

Isogenica has 3 partnered assets into clinical development. We develop proprietary LlamdA® VHH: highly versatile small format single domain antibodies, which we use to construct next โ€ฆSee details»

Isogenica - Overview, News & Similar companies | ZoomInfo.com

Isogenica is a drug discovery platform-licensing company focusing on the design and build of diverse, fully synthetic, antibody libraries for use in biopharmaceutical discovery. Partners can โ€ฆSee details»

Contact Us - Isogenica

Isogenica Ltd The Mansion House Chesterford Research Park Little Chesterford Essex CB10 1 XL UK " Careers at Isogenica. A career at Isogenica provides an opportunity to lead, execute โ€ฆSee details»

Isogenica - Contacts, Employees, Board Members, Advisors

Isogenica operates a range of discovery platforms supported by state-of-the-art methodologies for identifying antibody and peptide ligands.See details»

| One Nucleus

Isogenicaโ€™s partners can access a range of innovative, highly-diverse, antibody libraries as an excellent starting point for new biotherapeutic development programmes.. . All the companyโ€™s โ€ฆSee details»

Partnerships with Isogenica | Global Biopharma Collaborative โ€ฆ

Isogenicaโ€™s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including two clinical assets and eight partnered pre-clinical and discovery programs. โ€ฆSee details»

linkstock.net © 2022. All rights reserved